Suvretta Capital Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $2.54 Billion distributed in 98 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Kura Oncology, Inc. with a value of $150M, Insmed Inc with a value of $119M, Intra Cellular Therapies, Inc. with a value of $105M, Arcutis Biotherapeutics, Inc. with a value of $99.7M, and Meta Platforms, Inc. with a value of $96.4M.

Examining the 13F form we can see an increase of $147M in the current position value, from $2.39B to 2.54B.

Suvretta Capital Management, LLC is based out at New York, NY

Below you can find more details about Suvretta Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.54 Billion
Healthcare: $1.18 Billion
Technology: $335 Million
ETFs: $331 Million
Consumer Cyclical: $239 Million
Communication Services: $201 Million
Financial Services: $147 Million
Consumer Defensive: $68.7 Million
Industrials: $37.8 Million
Other: $1.86 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 98
  • Current Value $2.54 Billion
  • Prior Value $2.39 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 15 stocks
  • Additional Purchases 20 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 19 stocks
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.